Community monitoring of diabetic eye conditions
Official title: Feasibility of an Alternative Pathway for Hospital Referrals From Diabetic Eye Screening Wales (DESW) for People Suspected With Sight-threatening Diabetic Eye Disease Diabetic Maculopathy (FARSight-DM)
Run by Hywel Dda Health Board · NCT06955611 · Data updated 2026-11-12
This study is testing a new way for people with diabetes to have their eye conditions checked by local optometrists and doctors online to see if it makes monitoring easier and more effective.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Hywel Dda Health Board Academic / other |
| Locations | 1 site (Haverfordwest) |
| Status | Recruiting |
| Started | November 20, 2024 |
| Main results expected | August 2025 |
| Study ends | September 2025 |
| Registry record updated | May 2, 2025 |
| Trial ID | NCT06955611 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults with diabetes who have been referred for review of suspected diabetic maculopathy or pre-proliferative diabetic retinopathy.
✕Probably not a fit
Patients under 18 years old, those with diagnosed diabetic macular oedema, or individuals with proliferative diabetic retinopathy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates a new approach to monitor diabetic maculopathy and pre-proliferative diabetic retinopathy using community-based optometrists and virtual consultations with hospital ophthalmologists. The aim is to determine the feasibility and acceptability of this method for patients with diabetes, as well as its potential impact on healthcare resources and costs. By utilizing Optical Coherence Tomography (OCT) in community settings, the study seeks to improve early detection and management of these eye conditions, which are significant complications of diabetes.
Why it matters
Potential benefit: If successful, this approach could enhance early detection and treatment of diabetic eye conditions, potentially preserving vision for many patients.
How similar studies have gone: While this approach is innovative, similar studies have shown promise in utilizing community resources for managing diabetic eye conditions, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * People with diabetes referred to the hospital eye services for review of suspected diabetic maculopathy or pre-proliferative diabetic retinopathy in HDdUHB Exclusion Criteria: * \<18 years * People with diagnosed diabetic macular oedema * People with proliferative diabetic retinopathy
Where it's running
-
Hwyel Dda University Health Board
Haverfordwest, United Kingdom Recruiting
Study contacts
- Principal investigator: Eirini Skiadaresi, MD — Hywel Dda University Health Board
- Study coordinator: abigail Taylor
- Email: abigail.taylor@wales.nhs.uk
- Phone: 01437773823
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using AI to prevent vision loss from diabetes in underserved communities
This study is testing a new AI program to see if it can help people with diabetes in underserved communities get better eye care and follow-up after screenings.
-
Early angioplasty for diabetic foot syndrome
This study is testing if getting a quick angioplasty after being diagnosed with diabetic foot ulcers helps heal the wounds better than waiting for the procedure.
-
Using melatonin to improve sleep in patients with diabetic retinopathy
This study tests if taking melatonin can help people with diabetic retinopathy sleep better over eight weeks.
-
Preventing lower limb artery disease in adults with diabetes using a risk-prediction model and HAPA-based nursing
A risk-prediction model is tested in adults with type 2 diabetes to see if a nursing plan based on the HAPA model can reduce peripheral artery disease in the legs.
-
Corticosteroid for Diabetic Macular Edema (DME) in Adults with Diabetic Retinopathy
This trial tests whether intravitreal corticosteroid injections can influence inflammatory biomarkers and improve DME in adults with type 2 diabetes.
-
DiaFootCare: a mobile app to help adults with diabetic foot ulcers manage self-care in Oman
A mobile app called DiaFootCare will be tested to see if it helps adults with diabetic foot ulcers in Oman take better care of themselves and improve healing compared with usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.